Socioeconomic Factors May Not Predict Rheumatoid Arthritis Disease Activity
THURSDAY, Dec. 5, 2024 -- The impact of socioeconomic factors on disease activity in rheumatoid arthritis (RA) varies by academic or safety net hospital setting, according to a study published online Oct. 18 in ACR Open Rheumatology.
Joseph Kim, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues analyzed the impact of the Area Deprivation Index (ADI) on disease activity and cardiovascular comorbidity in RA. The analysis included data from 542 patients seen at an academic practice and 496 treated at a safety net hospital.
The researchers found that in the academic cohort, compared with those with low ADI scores (<3, less deprivation), those with high ADI scores (>8, more deprivation) had higher RA disease activity scores, as measured by the Routine Assessment of Patient Index and the Clinical Disease Activity Index, and more functional impairment, as measured by the Multidimensional Health Assessment Questionnaire, lower MyChart use, and different smoking history. The only significant difference seen in the safety net cohort was for smoking status.
"The absence of differences in RA disease activity and functional impairment in patients suggests that the ADI may not be as effective at predicting RA disease activity specifically in a safety net health care context," the authors write. "Identifying the discrepancies between the two systems may elucidate areas of improvement for patient care."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.